BioSpace News Archive

Press Releases

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

February 17, 2026
·
5 min read
Press Releases

Independent Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 12 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study

February 17, 2026
·
6 min read
Press Releases

Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services

February 17, 2026
·
3 min read
Press Releases

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - February 17, 2026

February 17, 2026
·
2 min read
Press Releases

Arvinas to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

February 17, 2026
·
1 min read
Press Releases

Axogen, Inc. to Participate in Multiple Upcoming March 2026 Investor Conferences

February 17, 2026
·
1 min read
Press Releases

BioCryst to Present at Upcoming March 2026 Investor Conference

February 17, 2026
·
1 min read
Press Releases

Ocular Therapeutix™ Reports Positive Results from Landmark SOL-1 Phase 3 Superiority Trial in Wet AMD

February 17, 2026
·
23 min read
Press Releases

Can-Fite Announces Scientific Breakthrough Publication Demonstrating Anti-Obesity Effect of Namodenoson

February 17, 2026
·
7 min read
Press Releases

Essential Pharma strengthens rare disease portfolio with acquisition of Ventavis® (iloprost trometamol) for adult primary pulmonary hypertension

February 17, 2026
·
2 min read